COMMUNIQUÉS West-GlobeNewswire

MESA LABS DECLARES QUARTERLY DIVIDEND

02/10/2024 - 20:00

LAKEWOOD, Colo., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0 [...]

Doheny Eye Institute To Receive Funding from NIH Award Supporting Cerebral Small Vessel Disease Detection

02/10/2024 - 19:47

Yuhua Zhang, Ph.D., Principal Investigator at Doheny Eye Institute and Professor of Ophthalmology at the David Geffen School of Medicine, UCLA, will lead the development of the next generation of advanced retinal [...]

SAFE - Report de l’Assemblée Générale et de la publication des résultats annuels dans l’attente de l’audience d’examen des plans de redressement du 18 octobre 2024

02/10/2024 - 19:30

Report de l’Assemblée Générale et de la publication des résultats annuels dans l’attente de l’audience d’examen des plans de redressement du 18 octobre 2024 Fleurieux-sur-l’Arbresle - France - le 2 octobre 2024 à 19h30 [...]

ARC Fertility Highlights Importance of Menopause Benefits During October Menopause Awareness Month

02/10/2024 - 18:05

CUPERTINO, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- As October marks World Menopause Awareness Month , ARC Fertility (ARC), a highly experienced national provider of innovative fertility, family-forming and women’s and [...]

Informations relatives au nombre total de droits de vote et d’actions composant le capital

02/10/2024 - 18:00

al Nantes, le 2 octobre 2024 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), société [...]

Results from a Phase I clinical trial of a dendritic cell targeting prophylactic HIV vaccine published in the Journal eClinical Medicine

02/10/2024 - 16:24

PRESS RELEASE Results from a Phase I clinical trial of a dendritic cell targeting prophylactic HIV vaccine published in the Journal eClinical Medicine Provides important validation of the safety and immunogenicity of [...]

AMN Healthcare Launches WorkWise: A Comprehensive Workforce Management & Talent Sourcing Technology

02/10/2024 - 16:05

Addresses staffing efficiency, enhances financial planning, and improves operational efficiency in healthcare systems through all-in-one technology solution to manage internal and external talent. DALLAS, Oct. 02, 2024 [...]

National Association of Dental Plans Celebrates 35th Anniversary

02/10/2024 - 16:00

NADP Marks Successes as Recognized Representative and Resource of Dental Benefits Industry DALLAS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The National Association of Dental Plans (NADP) proudly commemorates its 35 th [...]

Immix Biopharma Advances CAR-T NXC-201 to Expansion Cohort Dose Level in U.S. AL Amyloidosis Trial NEXICART-2

02/10/2024 - 15:32

Now dosing at dose expansion level of 450 million NXC-201 CAR+T cells. First cohort at 150 million CAR+T cells already successfully completed Each of these two doses have produced complete responses in prior clinical [...]

IntelGenx is Granted Court Approval of the Sale Proposal from atai Life Sciences AG

02/10/2024 - 15:21

MONTRÉAL, Oct. 02, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (the “ Company ” or “ IntelGenx ”), a leading drug delivery company focused on the development and manufacturing of pharmaceutical films, [...]

PharmAla to supply Harvard Medical School’s Maclean Hospital with LaNeo MDMA

02/10/2024 - 15:20

TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]

Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

02/10/2024 - 15:05

MIAMI, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]

Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.

02/10/2024 - 15:00

Name change to "Climb Bio" marks the Company’s transition and focus on developing treatments for immune-mediated diseases Climb Bio will begin trading on Nasdaq under the trading symbol "CLYM" effective October 3rd [...]

EVerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors in partnership with the French Blood Establishment (EFS) with unprecedented yields

02/10/2024 - 15:00

EVerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors in partnership with the French Blood Establishment (EFS) with unprecedented yields The disruptive, proprietary [...]

Medigene will Present at ASGCT 2024 and Host R&D Event

02/10/2024 - 15:00

Planegg/Martinsried, October 2, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies [...]

DepYmed to Present at the 9th World Rett Syndrome Congress

02/10/2024 - 15:00

FARMINGDALE, N.Y., Oct. 02, 2024 (GLOBE NEWSWIRE) -- DepYmed, Inc. (“DepYmed” or the “Company”) is a clinical-stage pharmaceutical company focused on developing transformative medicines for many poorly treated diseases [...]

Reviva to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

02/10/2024 - 14:30

CUPERTINO, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet [...]

Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments

02/10/2024 - 14:30

ATLANTA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, [...]

OneMedNet Announces Board Member Transition to Drive Growth Post-IPO

02/10/2024 - 14:30

MINNEAPOLIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), is pleased to announce a strategic [...]